Trial intelligence / Profile preview

Esmolol during endoscopic sinus surgery in patients with sinusitis or nasal polyps

ChiCTR2400095027Phase 4Recruiting

Sponsor
Tengzhou Central People's Hospital
Start
Dec 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of esmolol in rhinosinusitis and nasal polyp (2 arms), sponsored by Tengzhou Central People's Hospital. Primary endpoints: Blood pressure and heart rate values, Blood glucose levels and 2 more. Started Dec 2024; status: recruiting.

02

Drugs

esmolol
03

Conditions

rhinosinusitisnasal polyp

Beyond the preview

Go deeper on ChiCTR2400095027.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400095027.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call